A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus
NCT00982670 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2009-09-23
Summary
An increased prevalence of the metabolic syndrome has been found in patients with systemic lupus erythematosus in recent years.
Conditions
- Metabolic Syndrome
- Cardiovascular Risk Factors
- Systemic Lupus Erythematosus
Sponsors & Collaborators
-
Far Eastern Memorial Hospital
lead OTHER
Principal Investigators
-
Chun-Chen Yang, MD · Far Eastern Memorial Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2008-12-31
- Completion
- 2009-06-30
Countries
- Taiwan
More Related Trials
-
the Association Between Metabolic Syndrome and Its Components With Lupus Nephritis in Systemic Lupus Erythematosus Patients
NCT05964751 ·Status: UNKNOWN
-
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
NCT06167174 ·Status: RECRUITING
-
Bone Mineral Density in Patients with Childhood-onset Systemic Lupus Erythematous, in Relation to Disease Clinical Criteria
NCT06586359 ·Status: NOT_YET_RECRUITING
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
NCT04276701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE
NCT05230316 ·Status: UNKNOWN
-
Renal Survival in Patients with Lupus Nephritis
NCT06588192 ·Status: NOT_YET_RECRUITING
-
Assessment of Cognitive Function and Gut Microbiota Analysis in Real World Patients With Lupus Cerebrovascular Disease
NCT05636670 ·Status: UNKNOWN
-
Hematological Manifestations in Systemic Lupus Erythematosus Patients
NCT06936007 ·Status: COMPLETED
-
Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients
NCT05971498 ·Status: UNKNOWN
-
The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear
NCT02435368 ·Status: UNKNOWN
-
Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.
NCT06294483 ·Status: ENROLLING_BY_INVITATION
-
Observational Study Investigating Demographic and Clinical Characteristics of SLE Patients in Egypt
NCT07144514 ·Status: NOT_YET_RECRUITING
-
Gut Microbiota Dysbiosis in Lupus Nephritis
NCT06231303 ·Status: NOT_YET_RECRUITING
-
Premature Atherosclerosis in Systemic Lupus Erythematosus
NCT04037293 ·Status: UNKNOWN
-
Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN)
NCT03580291 ·Status: UNKNOWN ·Phase: PHASE2
-
Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus.
NCT05479071 ·Status: UNKNOWN
-
Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus
NCT00582881 ·Status: COMPLETED
-
O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus
NCT04440566 ·Status: COMPLETED ·Phase: NA
-
Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis
NCT02453997 ·Status: COMPLETED
-
Physical Activity in Patients With Systemic Lupus Erythematosus
NCT00985803 ·Status: UNKNOWN ·Phase: PHASE1
-
Assessment of Blood Indices in Systemic Lupus Erythematosus
NCT06872086 ·Status: NOT_YET_RECRUITING
-
The Expression Profile of New Complement Components in Childhood Lupus Nephritis
NCT05082363 ·Status: UNKNOWN
-
Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone
NCT00268567 ·Status: COMPLETED ·Phase: PHASE2/PHASE3